Compared with women with high THRα-2 tumor expression, women with low THRα-2 tumor expression were more likely to have ER- and PgR negative tumors, HER2-positive tumors, higher Ki67 and histological grade, as well as larger tumors, and were more likely to have ALNI (Table 2). The gene discussed is ESR1; the disease is neoplasm.